A 31-year-old woman newly diagnosed with HIV and her initial CD4 count is 238 cells/mm3. The plan is to immediately start antiretroviral therapy. Which one of the following medications requires baseline HLA-B*5701 testing to identify persons at increased risk of developing a medication-related hypersensitivity reaction?
A) Bictegravir
B) Doravirine
C) Efavirenz
D) Abacavir